Although the presentation, clinical symptoms, and laboratory findings of pediatric systemic
lupus erythematosus (SLE) are similar to those that are seen in adults, children and …

Objective To investigate whether 3 disease activity indices commonly used to evaluate
systemic lupus erythematosus (SLE) in adults are sensitive to clinical change in children …

Objective To determine the minimal clinically important differences (MCIDs) of validated
measures of systemic lupus erythematosus (SLE) disease activity in childhood‐onset SLE …

Objective To prospectively validate the provisional criteria for the evaluation of response to
therapy in children with systemic lupus erythematosus (SLE). Methods In this multicenter …

Abstract Objectives To evaluate the European Consensus Lupus Activity Measurement
(ECLAM) for responsiveness to change in disease activity when used in childhood‐onset …

Objective To devise a modified version of the Systemic Lupus International Collaborating
Clinics/American College of Rheumatology Damage Index (SDI) for use in children and …

Measurement of disease activity in systemic lupus erythematosus (SLE) is central to
evaluating outcomes, differences among SLE patient groups, responses to a new drug …

Abstract Objective The Systemic Lupus International Collaborating Clinics/American College
of Rheumatology (SLICC/ACR) Damage Index measures damage in adult patients with …

The survival rates in pediatric systemic lupus erythematosus (pSLE) have improved greatly
over recent decades. Increased life expectancy has meant that more children are growing …

Many instruments are available to assess disease activity and capture damage in patients
with systemic lupus erythematosus (SLE). These indices are frequently used in clinical trials …